XM does not provide services to residents of the United States of America.

U.S. STOCKS Hoth Therapeutics, gold miners, Gatos Silver



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Hoth Therapeutics, gold miners, Gatos Silver</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Futures tied to the S&P 500 pared some losses after a less-than-expected rise in weekly jobless claims calmed some worries over a cooling labor market. .N


At 9:03 ET, Dow e-minis 1YMc1 were down 0.04% at 41,035. S&P 500 e-minis ESc1 were down 0.08% at 5,525.75, while Nasdaq 100 e-minis NQc1 were down 0.30% at 18,905.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Yext <YEXT.N>, up 11.0%
** Stevanato Group <STVN.N>, up 10.7%
** Douglas Dynamics <PLOW.N>, up 9.6%

The top three NYSE percentage losers premarket .PRPL.NQ:
** C3.ai <AI.N>, down 19.9%
** BlackSky Technology <BKSY.N>, down 11.7%
** Toro <TTC.N>, down 10.9%

The top Nasdaq percentage gainer premarket .PRPG.O:
** Eastside Distilling <EAST.O>, up 257.8%


** Tesla TSLA.O: up 2.7% premarket
BUZZ - Gains on plans for Q1 2025 launch of full self-driving in Europe, China nL4N3KN0Q5


** IN8bio INAB.O: down 6.0% premarket
BUZZ - Falls after suspending development of two brain cancer drugs nL4N3KN0TG


** Frontier Communications Parent FYBR.O: down 9.5% premarket
BUZZ - Falls after Verizon says to acquire co nL4N3KN0VN


** Nio NIO.N: up 4.7% premarket
BUZZ - Rises on revenue growth, narrower loss in Q2 nL4N3KN0XJ


** Copart CPRT.O: down 5.8% premarket
BUZZ - Shares fall on lower Q4 profit nL4N3KN0X5


** JetBlue Airways JBLU.O: up 4.6% premarket
BUZZ - Jumps on Q3 revenue forecast boost nL4N3KN10H


** Gatos Silver GATO.N: up 6.8% premarket
BUZZ - Gains after First Majestic's $970 mln buyout deal nL4N3KN10P


** Fortive FTV.N: up 3.5% premarket
BUZZ - To spin off precision tech segment, shares rise nL4N3KN0XG


** V2X VVX.N: down 6.4% premarket
BUZZ - Drops on secondary offering nL1N3KN0H9


** Hoth Therapeutics HOTH.O: up 55.0% premarket
BUZZ - Jumps as skin toxicity drug shows promise in one patient nL4N3KN13K

** Newmont NEM.N: up 1.5% premarket

** Barrick Gold GOLD.N: up 1.8% premarket ** Gold Fields GFI.N: up 2.0% premarket ** Sibanye Stillwater SBSW.N: up 1.9% premarket
BUZZ - Gold miners gain on rising odds of deeper US rate cut nL4N3KN14C


** Voyager Therapeutics VYGR.O: up 4.8% premarket
BUZZ - Climbs on expanded licensing deal with Novartis nL4N3KN14U


(Rajarshi Roy and Anuja Bharat Mistry)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.